Related Experiment Video
Updated: Jun 9, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
Published on: March 29, 2024
New-Onset Acute Heart Failure With Reduced Ejection Fraction Associated With Severe Microcytic Anemia
Annabel Ricci1, Cassandra Hunt1, Chabelly Gomez2
1St. George's University School of Medicine True Blue Grenada.
Severe microcytic anemia can precipitate heart failure with reduced ejection fraction (HFrEF). Prompt diagnosis and treatment of anemia are crucial for managing HFrEF and identifying reversible causes.
Area of Science:
- Cardiology
- Hematology
- Internal Medicine
Background:
- Severe microcytic anemia can be a reversible cause of heart failure with reduced ejection fraction (HFrEF).
- Undetermined etiology of severe anemia presents diagnostic challenges in heart failure patients.
Purpose of the Study:
- To highlight the diagnostic complexity of severe microcytic anemia in a patient with new-onset heart failure.
- To emphasize the hemodynamic consequences and management of anemia as a precipitating factor for HFrEF.
Main Methods:
- Case report of a 60-year-old woman with new-onset heart failure and severe microcytic anemia.
- Clinical presentation, laboratory investigations (hemoglobin, MCV, iron studies), and initial management are described.
Main Results:
- Patient presented with acute dyspnea, chest pain, edema, severe microcytic anemia (Hb 4.5 g/dL, MCV 60.8 fL), and HFrEF (EF 33%).
- Iron studies indicated iron deficiency anemia; bleeding source was not identified.
- Patient received blood transfusion and intravenous iron for stabilization.
Conclusions:
- Severe anemia should be considered a potential precipitating factor in new-onset heart failure.
- Comprehensive evaluation is necessary to identify and treat potentially reversible causes of anemia in HFrEF.
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
